Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma

Melanoma is the deadliest form of skin cancer and has an incidence that is rising faster than any other solid tumor. Metastatic melanoma treatment has considerably progressed in the past five years with the introduction of targeted therapy (BRAF and MEK inhibitors) and immune checkpoint blockade (an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Teresa, Amaria, Rodabe N., Spencer, Christine, Reuben, Alexandre, Cooper, Zachary A., Wargo, Jennifer A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296084/
https://www.ncbi.nlm.nih.gov/pubmed/25610709
http://dx.doi.org/10.7497/j.issn.2095-3941.2014.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296084/
https://www.ncbi.nlm.nih.gov/pubmed/25610709
http://dx.doi.org/10.7497/j.issn.2095-3941.2014.04.002

Ejemplares similares